Spyre Therapeutics CEO Turtle Cameron sells common shares worth $1.42 million

PUBT · 2d ago
Spyre Therapeutics CEO Turtle Cameron sells common shares worth $1.42 million
  • Spyre Therapeutics CEO Turtle Cameron sold 15,000 common shares on Aug. 3 at weighted-average prices of $93.97 to $97.46.
  • Cameron’s direct holdings fell to 567,540 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001636282-26-000099), on August 05, 2026, and is solely responsible for the information contained therein.